RAPP — RAPPORT THERAPEUTICS, INC.

Ownership history in TRV GP V, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which TRV GP V, LLC reported a position in RAPPORT THERAPEUTICS, INC. (RAPP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
59.95% (2025 Q3)
Avg. % of fund
51.93%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 7,135,233 — 0% 50.44% $216.5M $30.34
2025 Q3 UNCHANGED 7,135,233 — 0% 59.95% $211.9M $29.70
2025 Q2 UNCHANGED 7,135,233 — 0% 48.98% $81.1M $11.37
2025 Q1 UNCHANGED 7,135,233 — 0% 57.21% $71.6M $10.03
2024 Q4 INITIATED 7,135,233 — — 43.06% $126.6M $17.74
% of Fund (quarterly)    RAPP price (monthly, adj. close)

Other funds also holding RAPP

As of 2025 Q4 — sorted by position size

TRV GP VI, LLC 19.8% ARCH Venture Management, LLC 3Y 7Y 17.36% JOHNSON & JOHNSON 3Y 9.76% Cormorant Asset Management, LP 3Y 7Y 4.25% Sofinnova Investments, Inc. 3Y 7Y 2.49% Vestal Point Capital, LP 1.14% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 0.95% Sio Capital Management, LLC 3Y 7Y 0.88% Siren, L.L.C. 0.64% Artia Global Partners LP 3Y 0.6%
← Back to TRV GP V, LLC Holdings